ABSTRACT
INTRODUCTION
Many individuals in the community are prescribed drugs with central nervous system (CNS) depressant effects. A single dose of central nervous system depressant drugs (CNS-Ds) including benzodiazepines, opioids and tricyclic antidepressants can cause acute impairment in activities such as driving, 1, 2 and an array of cognitive and psychomotor functions underlying everyday activities. [3] [4] [5] [6] These cognitive and psychomotor effects include impaired visual attention and reaction time, 3, [7] [8] [9] [10] attentional set-shifting, 11 planning, 12 and working memory, 13 and increased impulsivity. 14 Similarly, acute cognitive effects have also been reported with atypical antipsychotics. 10, [15] [16] [17] These acute effects have been demonstrated in experimental studies conducted mostly on healthy volunteers and to a lesser extent, on patient groups.
In contrast, research is lacking on the extent of impairment in patients who take CNS-Ds in overdose even though CNS-D overdose is one of the most common modes of poisoning in developed countries, accounting for around 71,000 hospitaltreated drug overdoses in the US (2006), 18 39 ,000 in the UK (mid 2009 -mid 2010) 19 and 12,000 in Australia (mid 2007 -mid 2008) . 20 An extensive literature search retrieved only two studies that examined cognitive functioning following CNS-D overdose. Both reported anterograde amnesia following benzodiazepine overdose in ward patients, which improved from day 1 to day 2 after overdose. 21, 22 Given the evidence of acute effects of single doses of a variety of CNS-Ds, the sedative effects of overdose would obviously lead to profound impairments in number of cognitive and psychomotor domains in the acute stage. While such deficits are unlikely to be pertinent to the functionality of an inpatient who is under scrutiny of medical staff, in
Chapter 5 150 contrast, even a subclinical cognitive impairment could be consequential if the effects persist at the time of discharge, when the individual is otherwise deemed fit enough to return to the community. Length-of-hospital-stay statistics, particularly those in the UK 19 and Australia 20 indicate that majority of these patients are discharged from hospitals within 24-48 hours of admission. Given that acute effects of even therapeutic doses can last overnight, 1 the length of hospital stay following overdose could be too short for the adverse cognitive effects of the drugs to wear off -yet these effects may not be detected on the basis of routine history and clinical examination by staff making the decision to discharge the patient.
The aim of the present study was to determine whether patients with CNS-D overdose are cognitively impaired at the time they are clinically deemed fit to be discharged from hospital. We focused our assessment on three neurocognitive domains underpinning daily activities of social and professional life: a) visual attention and visuomotor skills, b) executive functions and working memory and c) impulsivity and decision-making.
Using a battery of neuropsychological tests tapping into the above domains, we compared the performance of a group of patients following CNS-D overdose with that of a Control Group with non-CNS-depressant drug (CNS-ND) overdose at the point of discharge from the hospital-treated overdose episode. Given the broad range of acute cognitive deficits caused by therapeutic doses of CNS-D, we hypothesized the CNS-D Group would be impaired in all domains when compared to the Control Group.
Chapter 5 Database, which is used as a digital repository for clinical and research purposes. The structure of this database has been described elsewhere. 24 Ethics approval for the study was granted by the Hunter New England Human Research Ethics Committee.
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METHOD
Recruitment of participants
Patients aged between 18 and 70 years admitted to the hospital following deliberate self-poisoning were prospectively screened for eligibility during daily ward-rounds. Those who overdosed with benzodiazepines, atypical antipsychotics or opioids were considered for inclusion into the CNS-D Group, whereas those who overdosed with acetaminophen, selective serotonin-reuptake inhibitors (SSRIs) or serotonin-noradrenaline-reuptake inhibitors (SNRIs) were considered for inclusion into the Control Group. Drug overdose was ascertained based on history, clinical picture and circumstantial evidence (e.g. availability of empty blister packs). A drug overdose was defined as acute administration of 2 or more times the defined daily dose (DDD: the assumed average maintenance dose per day for a drug used for its Informed written consent was obtained from those who were willing to participate.
Neuropsychological assessment was carried out just before they were due to leave the hospital.
Neuropsychological assessment
Three neurocognitive domains and general intelligence were assessed using a battery of validated neuropsychological tests. TMT-A consists of encircled numbers from 1 to 25 positioned irregularly on a sheet of paper. Subjects must connect these numbers in ascending order using a pencil as TMT-B in addition taps into cognitive flexibility or the ability to switch attention between two conceptual sets. [30] [31] [32] The difference between the completion times of TMT-B and TMT-A (TMT B-A) reflects the executive component of the task as it is generally agreed that subtraction controls for visual scanning and movement time.
Letter-Number Sequencing (LNS) 28 (duration: ~ 5 minutes).
This is a test of working memory capacity. The examiner reads aloud a group of numbers and letters (e.g. V-1-J-5) and the subjects have to answer by recalling the numbers first in ascending order and then the letters in alphabetical order (1-5-J-V).
The test starts with a sequence of two items (one number and one letter), and the span is increased until the subject fails all three sequences at a given length. The number of correct sequences is the test score.
National Adult Reading Test (NART) 29 (duration: ~ 5 minutes).
The NART was administered to estimate pre-overdose IQ, as a potential covariate of 
Cambridge Neuropsychological Test Automated Battery (CANTAB) 27 (duration: 35 -40 minutes).
The component tests of CANTAB have been modified from well documented animal testing paradigms, so that behavioral data can be also related to neural systems underlying distinct cognitive domains analyzed by component tests. 31 Test administration and scoring is computerized so that minimizing any biases that can be The order of the two conditions was counterbalanced among subjects in each group.
The main outcome measure of interest is designated P, which is the probability that the color chosen by the subject at the point of decision is correct (with a maximum possible value of 1), based on the evidence available at that time, and assuming each box has a 0.5 probability of assuming one of the two colors. Thus, P is an index of the rationality of the decision made by the subject: lower the P value, the more impulsive the decision is. P was calculated separately for the Fixed-Win (IST-FWP) and
Decreasing-Win Conditions (IST-DWP).
Stockings of Cambridge (SOC, duration ~ 10 minutes). SOC is a
computerized version of the Tower of London task and tests planning and spatial working memory. 34 The goal of the task is to rearrange a set of three balls in a minimum number of moves to match a sample pattern. Therefore, subjects have to plan their moves before starting to move the balls. The assessed task has 12 trials (2 x 2-move, 2 x 3-move, 4 x 4-move and 4 x 5 move problems). The outcome measures that we focused on were the number of problems solved in minimum moves and the mean number of the moves spent in solving an n-move problem (Mean-n-Moves), n being 2, 3, 4 or 5.
Demographic and clinical data
Demographic information (gender, age, and years of education) was collected at the time of testing. The following clinical data related to the present study were extracted from the Hunter Area Toxicology Services (HATS) database:
The data fields retrieved from the HATS database include those related to longterm clinical conditions (viz. major psychiatric illnesses, regular medication) and the episode of drug-overdose (viz. type and dose of drug taken in overdose, time of overdose, length of hospital stay, co-ingestion of alcohol, lowest GCS score recorded, any mechanical ventilation and in-ward treatment with potentially sedative drugs).
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Data analysis
Sample characteristics were compared between the two groups with independent sample t-tests (for continuous variables) and Chi-squared tests (for categorical variables) ( Table 1 
RESULTS
Sample characteristics
We considered 236 patients for eligibility, excluded 27 The sample characteristics are displayed in Table 1 . The CNS-D Group was significantly older than the Control Group. Gender distribution, level of education, IQ, time from overdose to testing and the magnitude of overdose were similar between the two groups. Nearly half of the participants in each group had a major psychiatric illness (those diagnosed in the present sample were major depression, bipolar disorder and schizoaffective disorder). Around one third of each group had co-ingested alcohol. Nine patients in the CNS-D group had a lowest recorded GCS score less than nine after overdose. Of these, eight received mechanical ventilation.
The mean time from exposure to testing in the CNS-D Group was 32 hours, and 85% of this group were tested within 48 hours after exposure. 
CNS-D = central nervous system depressant, DDD = defined daily dose
Group comparisons of neurocognitive measures
One extreme outlier for TMT-A and one for CRT latency were removed from the dataset prior to analysis. Summary measures based on the rest of the data are displayed in Table 2 . All outcome measures were significantly impaired in the CNS-D Group compared with the Control Group. Other significant determinants of performance were age and IQ. Education, gender, psychiatric illnesses, co-ingestion of alcohol, in-ward sedative treatment and time from exposure to testing were not significantly associated with any of the outcome measures in the MLR analysis.
Having observed a significant Group and Age effect on many outcome measures, a new variable Group x age interaction was entered into the MLR models to explore any difference in the effect of age on outcome measures in two Groups. However, that did not significantly improve any of the models, so the final MLR models contained only the main effects (Table 2) .
Visual attention and visuomotor skills
Both TMT-A and CRT were significantly prolonged in the CNS-D Group.
Test performance was also impaired with increasing age but was not influenced by Table 2) . In the mixed ANOVA models for the SOC Mean-n-Moves based on Group (between-subject factor), task difficulty (i.e. minimum possible moves for a problem:
LNS. CNS-D Group
2, 3, 4 or 5: within-subject factor) and other covariates, only age turned out to be a significant covariate so that the final analysis for Group x Task Difficulty model was 
Unplanned comparisons
Subgroup comparisons
Three subgroup analyses were conducted on each main outcome measure with series of one-way ANOVA tests and subsequent pairwise comparisons. These SSRIs/SNRIs (n=34).
One-way ANOVA tests and subsequent Bonferroni-corrected pairwise comparisons did not show any significant differences. No multivariate analyses were performed for these subgroups.
Intra-Group analysis for CNS-D overdose
Stepwise MLR models were fitted including the variables used in the main analysis and a new variable, lowest recorded GCS score following overdose (as a measure of degree of maximum CNS-depression caused by overdose) which was modelled as a dichotomous variable (<9 vs. 
DISCUSSION
To our knowledge, this is the first study that has examined subclinical impairment in a range of cognitive domains following clinical 'recovery' from CNS- were increasingly impaired with increasing age whereas these relatively low-level tasks were not dependent on IQ. As has been observed in healthy populations 35, 37 measures of executive functions and working memory were generally dependent on both age and IQ, except SOC which did not significantly correlate with IQ and LNS which did not correlate with age. In contrast to the other two domains, older age was associated with lower impulsivity and more rational decision-making.
Although we could not find comparable previous studies on cognitive effects of drug overdose, and the present CNS-D Group is too heterogeneous to compare with well-controlled samples in experimental studies on specific drugs, the cognitive deficits in the CNS-D Group are generally similar to the acute effects reported in previous experimental studies. Such adverse effects of benzodiazepines and opioids include impaired visual attention and psychomotor skills, 3, 7-10 attentional setshifting, 11 planning 12 and working memory, 13 and increased impulsivity. Residual cognitive impairments in patients discharged following CNS-D overdose could affect their daily activities during the immediate post discharge period. They represent a relatively young cross-section of the population and, unlike the elderly, they tend to return to social and working environments with high cognitive demands. In this respect, driving is one activity of concern in modern society. According to cognitive models of driving, 38, 39 visual attention, visuomotor skills, and ability to switch attentional-set are among major determinants of driving behavior. The regression models for tests that tap into these domains (CRT, TMT-A and TMT-B) suggest that drug effects could be equivalent to a cognitive aging by 10-20 years. This could be detrimental particularly because the impairment is acute and the patients do not have time to develop coping mechanisms as they do with normal ageing. The impairment associated with CNS-D overdose cannot be solely attributed to impaired processing speed however. Time-independent tasks (SOC, LNS and IST)
show that CNS-D overdose is associated with impaired planning and working memory and higher impulsivity in decision making. Worsening SOC task performance observed with increasing executive demands is similar to the pattern that has been reported in patients with frontal lobe lesions. 34 The findings of the present study have research and clinical implications. Which activities a patient should refrain from depends on a patient's regular social and professional commitments. Driving would be one of these, owing to its complex and time-constrained cognitive and psychomotor demands and safety implications of errors. In the light of the observation that they tend to make more errors in executive tasks and more impulsive in decision-making, these patients should also be advised to be more cautious in making major decisions in their social and professional life on their own. For how long a patient should refrain from such activities is open to clinical judgment until evidence from follow up studies and real-life outcome studies is available.
